Synthesis of 5-chloro-1,3-benzothiazol-2(3H)-one (1e)
The conventional and microwave-assisted methods for synthesis of 5-chloro-1,3-benzothiazol-2(3H)-one have been reported before [8, 15, 24] . In this study, we used the microwave-assisted method for synthesis of compound 1e.
Synthesis of 5-chloro-6-acyl-1,3-benzothiazol-2(3H)-one derivatives (1f, 1g)
Microwave irradiation condition A mixture of 5-chloro-1,3-benzothiazol-2(3H)-one (1e) (0.1 mol) and the appropriate benzoic acid derivatives (0.3 mol) in polyphosphoric acid was heated to 140 o C and stirred for 2 h under MWI. The reaction mixture was poured into crushed ice. After stirring for 1 h, the precipitated solid product was collected by suction filtration, washed with 5% NaHCO 3 and water, dried, and crystallized from the appropriate solvent.
5-Chloro-6-(4-fluorobenzoyl)-1,3-benzothiazol-2(3H)-one (1f)
The crude product was purified by column chromatography using dichloromethane (DCM). The collected product 1f was crystallized from ethanol/water with a yield of 64%. m. 
5-Chloro-6-(4-methylbenzoyl)-1,3-benzothiazol-2(3H)-one (1g)
The crude product was purified by column chromatography using DCM. The collected product 1g was crystallized from 2-propanol/water with a yield of 72%. m. 
Synthesis of ester derivatives (2a-2g)
A mixture of the appropriate core compound (1a-1g) (0.05 mol), potassium carbonate (0.08 mol) and ethyl bromoacetate (0.08 mol) in 100 mL acetone was heated under reflux and stirred for 20 min under MWI. 100 g ice water was added to the cooled (0-10°C) reaction mixture and stirred. The precipitate was collected on a suction filter, washed with water, dried, and crystallized from the appropriate solvent. 
Ethyl

Synthesis of acid derivatives (3a-g)
Ester derivatives (2a-g) (0.022 mol) and potassium hydroxide (0.025 mol) in 150 mL ethanol/water were refluxed for 15 min under MWI. After cooling to room temperature, the mixture was acidified with acetic acid to give a precipitate. The product was collected by suction filtration, washed with water, dried, and crystallized from the appropriate solvent. 
Synthesis of amide derivatives
Acid derivatives (0.002 mol) and SOCl 2 (0.06 mol) in 15 mL toluene were refluxed for 1 h under MWI. The final mixture was evaporated to dryness and 20 mL tetrahydrofurane was added. The solutions of the acid chloride derivatives were mixed with potassium carbonate (0.004 mol) and the appropriate piperazine derivatives (0.004 mol) THF. The mixture was refluxed for 20 min under MWI and poured into ice water. Then, the precipitated solid material was filtered and crystallized from the appropriate solvent.
3-[2-(4-Methylpiperazin-1-yl)-2-oxoethyl]-1,3-benzothiazol-2(3H)-one (5a)
Crystallized from cyclohexane with a yield of 46.4%. m. 
3-[2-(4-Ethylpiperazin-1-yl)-2-oxoethyl]-1,3-benzothiazol-2(3H)-one (6a)
Crystallized from ethyl acetate/petroleum ether with a yield of 30%. m. Fluorobenzoyl)-3-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-1,3-benzothiazol-2(3H) 
6-(4-
3-[2-(4-Ethylpiperazin-1-yl)-2-oxoethyl]-6-(4-fluorobenzoyl)-1,3-benzothiazol-2(3H)-one (6b)
Crystallized from tetrahydrofurane/water with a yield of 37%. m. 
6-(4-Fluorobenzoyl)-3-{2-oxo-2-[4-(propan-2-yl)piperazin-1-yl]ethyl}-1,3-benzothiazol-2(3H)-one (7b)
Crystallized from acetone/cyclohexane with a yield of 31%. m. 
3-[2-(4-Butylpiperazin-1-yl)-2-oxoethyl]-6-(4-fluorobenzoyl)-1,3-benzothiazol-2(3H)-one (8b)
Crystallized from acetone/cyclohexane with a yield of 54%. m. 
6-(4-Methylbenzoyl)-3-[2-(methylpiperazin-1-yl)-2-oxoethyl]-1,3-benzothiazol-2(3H)-one (5c)
Crystallized from acetone/cyclohexane with a yield of 49%. m. 
3-[2-(Ethylpiperazin-1-yl)-2-oxoethyl]-6-(4-methylbenzoyl)-1,3-benzothiazol-2(3H)-one (6c)
Crystallized from cyclohexane with a yield of 56.6%. m. 
6-(4-Methylbenzoyl)-3-[2-oxo-2-[4-(propan-2-yl)piperazin-1-yl]ethyl]-1,3-benzothiazol-2(3H)-one (7c)
Crystallized from cyclohexane with a yield of 63%. m. 
3-[2-(Butylpiperazin-1-yl)-2-oxoethyl]-6-(4-methylbenzoyl)-1,3-benzothiazol-2(3H)-one (8c)
Crystallized from tetrahydrofurane /water with a yield of 80%. m. 
6-(4-Methoxybenzoyl)-3-[2-(methylpiperazin-1-yl)-2-oxoethyl]-1,3-benzothiazol-2(3H)-one (5d)
Crystallized from acetone/cyclohexane with a yield of 53%. m. -1-yl)-2-oxoethyl]-6-(4-methoxybenzoyl)-1,3-benzothiazol-2(3H) 
3-[2-(Ethylpiperazin
6-(4-Methoxybenzoyl)-3-[2-oxo-2-[4-(propan-2-yl)piperazin-1-yl]ethyl]-1,3-benzothiazol-2(3H)-one (7d)
Crystallized from cyclohexane with a yield of 34%. m. 1 H-NMR (400 MHz, DMSO-d 6 ) δ: 8.10 (1H), 7.76 (2H), 7.70 (1H), 7.35 (1H), 7.10 (2H), 5.00 (2H), 3.87 (3H), 3.57 (2H), 3.45 (2H), 2.47 (2H), 2.34-2.32 (4H), 1.55-1.37 (2H), 1.37-1.18 (2H), 0.90 (3H). 13 -3-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-1,3-benzothiazol-2(3H) -3-{2-oxo-2-[4-(propan-2-yl)piperazin-1-yl]ethyl}-1,3-benzothiazol-2(3H) 
5-Chloro
5-Chloro-6-(4-fluorobenzoyl)-3-[2-(methylpiperazin-1-yl)-2-oxoethyl]-1,3-benzothiazol-2(3H)-one (5f)
Crystallized from acetone/cyclohexane with a yield of 47%. m. -6-(4-fluorobenzoyl)-3-[2-oxo-2-(4-(propan-2-yl)piperazin-1-yl) -6-(4-methylbenzoyl)-3-[2-oxo-2-(4-(propan-2-yl)piperazin-1-yl) 
5-Chloro
